Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: Comparison with rest-redistribution thallium-201

Journal of the American College of Cardiology

Volumn 29, Issue 6, 1997, Pages 1226-1233

  Matsunari, Ichiro ^a   Fujino, Susumu ^b   Taki, Junichi ^a   Senma, Junji ^b   Aoyama, Takahiko ^b   Wakasugi, Takanobu ^b   Hirai, Jun Ichi ^b   Saga, Takashi ^b   Yamamoto, Shinichiro ^b   Tonami, Norihisa ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b Departments of Radiology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REVASCULARIZATION; SCINTIANGIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; GATED BLOOD-POOL IMAGING; HEART; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROC CURVE; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 17344375070     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00061-2     Document Type: Article

References (22)

1. Higley B, Smith FW, Smith T, et al. Technetium-99m-1, 2-bis[bis(2-ethoxyethyl) phosphino]ethane human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent . J Nucl Med. 34:1993;30-38.
2. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol. 72:1993;1015-1019.
3. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med. 34:1993;1478-1484.
4. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med. 35:1994;594-600.
5. 201Tl imaging and coronary angiography in a phase III multicenter trial . Circulation. 91:1995;313-319.
6. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 87:1993;1-20.
7. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 87:1993;1630-1641.
8. 99mTc-sestamibi . Circulation. 89:1994;2552-2561.
9. 18F]fluorodeoxyglucose . Circulation. 89:1994;578-587.
10. Marzullo P, Sambuceti G, Parodi O, et al. Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability comparison with postrevascularization functional recovery . J Nucl Cardiol. 2:1995;309-316.
11. Matsunari I, Fujino S, Taki J, et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med. 36:1995;1961-1967.
12. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 8:1978;283-298.
13. Matsunari I, Tanishima Y, Taki J, et al. Early and delayed technetium-99m-tetrofosmin myocardial SPECT compared in normal volunteers. J Nucl Med. 37:1996;1622-1626.
14. Pace L, Cuocolo A, Maurea S, et al. Reverse redistribution in resting thallium-201 myocardial scintigraphy in patients with coronary artery disease relation to coronary anatomy and ventricular function . J Nucl Med. 34:1993;1688-1692.
15. Vera DR, Stadalnik RC, Metz CE, Pimstone NR. Diagnostic performance of a receptor-binding radiopharmacokinetic model. J Nucl Med. 37:1996;160-164.
16. vom Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation. 90:1994;2356-2366.
17. Metz CE, Wang PL, Kronman HB. A new approach for testing the significance of differences between ROC curves measured from correlated data. Deconinck F. Information Processing in Medical Imaging. 1984;432-445 Nijhoff, The Hague.
18. Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin I: uptake into isolated adult rat ventricular myocytes and subcellular localization . J Nucl Cardiol. 2:1995;317-326.
19. Matsunari I, Fujino S, Taki J, et al. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Am J Cardiol. 77:1996;350-354.
20. Sinusas AJ, Shi Q-X, Saltzberg MT, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow experimental validation in an intact canine model of ischemia . J Nucl Med. 35:1994;664-671.
21. 201Tl in the presence of a severe coronary artery disease. Circulation. 89:1994;2332-2341.
22. 201Tl in a model of acute coronary reperfusion. Circulation. 94:1996;2605-2613.